Jim Kublin, M.D., M.P.H.

faculty member

Jim Kublin, M.D., M.P.H.

Principal Staff Scientist
Vaccine and Infectious Disease Division, Fred Hutch

Executive Director
HIV Vaccine Trials Network (HVTN)

Medical Director
Seattle Malaria Clinical Trials Center (Seattle MCTC)

Mail Stop: E3-300

Other Appointments & Affiliations

Clinical Professor, Global Health
University of Washington


M.P.H., Johns Hopkins School of Public Health, 1997

M.D., Georgetown University School of Medicine, 1988

B.S., Biology, Georgetown University, 1984

Research Interests

HIV and tuberculosis (Tb) vaccine research and development

Human challenge experiments

Microbiome modulation of immunity

Immune activation—polymicrobial infections

Combination HIV prevention

Malaria clinical trials/vaccines

Molecular epidemiology

Current Projects

Developing and testing preventive HIV and Tb vaccines via the HVTN

The role of the microbiome in training the immune system, particularly during early life, that predisposes individuals to immune mediated diseases later in life and that results in vaccine response heterogeneity.

Find A Clinical Trial

Dr. Kublin in the News

Study points toward progress on TB vaccines

Hutch News - March 16, 2020

Improving HIV clinical trials with mobile technology

Science Spotlight - July 15, 2019

GMO malaria saves the day

Science Spotlight - February 20, 2017

On the path to a new-generation malaria vaccine

Hutch News - January 04, 2017

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210